[Antineoplastic effect of L-asparaginase].
D000818:Animals; D001215:Asparaginase / Q000008:administration & dosage / Q000627:therapeutic use*; D001377:Azaserine / Q000008:administration & dosage; D002455:Cell Division / Q000187:drug effects; D003609:Dactinomycin / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D004926:Escherichia coli / Q000201:enzymology*; D006131:Growth Inhibitors; D006801:Humans; D007940:Leukemia L5178 / Q000188:drug therapy* / Q000473:pathology; D007942:Leukemia, Experimental / Q000188:drug therapy*; D007945:Leukemia, Lymphoid / Q000188:drug therapy* / Q000473:pathology; D051379:Mice
D006131:Growth Inhibitors; D003609:Dactinomycin; D001377:Azaserine; D001215:Asparaginase
Działanie przeciwnowotworowe L-asparaginazy.